Taking these observations together with aforementioned effects of NEDD4L/KLF5 on ROS, ferroptosis and DNA damage, we thereby illustrated that NEDD4L/KLF5 could manipulate ESCC resistance to radiotherapy. Here, NEDD4L is linked to esophageal squamous cell carcinoma.